Consumer Health Healthcare
Junshi Biosciences Secures Australian Approval for Toripalimab, First Immuno-Oncology Treatment for Nasopharyngeal Carcinoma
Shanghai Junshi Biosciences Co., Ltd , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercializati...
January 21, 2025 | News
HKUST Researchers Develop World's Smallest Multifunctional Biomedical Robot for Precision Diagnosis and Treatment
Researchers from the School of Engineering of the Hong Kong University of Science and Technology (HKUST) have successfully developed the world's ...
January 21, 2025 | News
Guangzhou Fermion Partners with Simcere to Advance Clinical-Stage SSTR4 Agonist for Pain Management
Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceutical Group Limited have announced a partnership to develop a clinical-stage pain treatment ass...
January 20, 2025 | News
HALEO Partners with Munich Re Australia to Transform Disability Management Through Sleep Care
HALEO, a leader in virtual care for sleep disorders, is proud to announce a partnership with Munich Re Australia aimed at enhancing disability management t...
January 17, 2025 | News
IMPACT Therapeutics’ Senaparib Gains NMPA Approval as First-Line Maintenance Therapy for Advanced Ovarian Cancer
IMPACT Therapeutics ("IMPACT"), a biopharmaceutical company focusing on the discovery and development of targeted anti-cancer therapeutics based on synthet...
January 17, 2025 | News
Nextbiomedical Secures FDA IDE Approval for U.S. Clinical Trial of Nexsphere-F™ in Knee Osteoarthritis
NEXTBIOMEDICAL CO., LTD, a KOSDAQ-listed innovative medical device company in South Korea, proudly announced that it has received Investigational Devi...
January 16, 2025 | News
CMU Hosts International Forum Showcasing Taiwan’s Leadership in Extracellular Vesicle Technology
China Medical University (CMU) and Healthcare System hosted the International Forum of Extracellular Vesicles Technology and Novel Therapeutics to highligh...
January 16, 2025 | News
R-Bridge Healthcare Fund Provides $40M Financing to Mirxes to Accelerate Global Expansion of Cancer Early Detection Solutions
R-Bridge will provide bespoke financing of US$40 million with a synthetic royalty structure and f...
January 14, 2025 | News
Regor’s Oral GLP-1RA RGT-075 Shows 5% Placebo-Adjusted Weight Loss in Phase 2a Trial with Strong Safety Profile
Regor announced its 12-week single-dose Phase 2a trial results for RGT-075, a once-daily oral GLP-1RA, reporting 5% placebo-adjusted weight-loss with no ...
January 13, 2025 | News
MSD’s GARDASIL® Becomes First HPV Vaccine Approved for Males in China
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the National Medical Products Administration (NMPA) of China ...
January 10, 2025 | News
DIOSynVax Introduces New Influenza Vaccine Portfolio and Advisory Board to Tackle Global Pandemic Threats
DIOSynVax, a clinical-stage biotechnology company at the forefront of developing innovative, broadly protective vaccines, built on the safety demonstrated ...
January 09, 2025 | News
Zuellig Pharma Acquires Propan to Strengthen Consumer Health Portfolio in the Philippines
Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that it has completed the acquisition of Propan, a market leading brand in th...
January 07, 2025 | News
Technoderma Medicines Announces Positive Phase 2a Results for TDM-180935 in Atopic Dermatitis
Technoderma Medicines, Inc. ("the Company"), a clinical stage biopharmaceutical company, is pleased to report the Company has completed its Phase 2a clinic...
January 07, 2025 | News
Docquity and HCDC Join Forces to Advance Preventive Medicine Education for Over 3,000 Vietnamese HCPs
Through this multi-year initiative, HCDC will tap on Docquity’s digital capabilities and reach to arm over 3,000 HCPs across diverse fields with brea...
January 06, 2025 | News
Most Read
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
